QL
EWTX icon

Quarry LP’s Edgewise Therapeutics EWTX Stock Holding History

Quarry LP’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$189K Buy
6,000
+200
+3% +$5.77K 0.03% 347
2025
Q4 		$144K Buy
+5,800
New +$116K 0.02% 336
2025
Q3 		– Sell
-311
Closed -$4.08K – 2269
2025
Q2 		$4.08K Sell
311
-889
-74% -$12.8K ﹤0.01% 1496
2025
Q1 		$26.4K Sell
1,200
-800
-40% -$21K 0.01% 1039
2024
Q4 		$53.4K Sell
2,000
-1,500
-43% -$47.8K 0.01% 718
2024
Q3 		$93.4K Sell
3,500
-10,500
-75% -$209K 0.02% 452
2024
Q2 		$252K Buy
+14,000
New +$244K 0.07% 131

Other funds holding EWTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Quarry LP's EWTX Position: Q1 2026 in Review

Quarry LP increased its Edgewise Therapeutics (EWTX) stake by 3.4% in Q1 2026, buying an estimated $5.77K and bringing the position to 6,000 shares worth $189K. The position accounts for 0.03% of the portfolio, ranked #347.

Quarry LP first reported a position in EWTX in Q2 2024 and has held it in 7 quarters since. The position peaked at $252K in Q2 2024. 214 funds tracked by Wall St. Rank hold EWTX as of Q1 2026.

  • Quarry LP held 6,000 shares of Edgewise Therapeutics worth $189K as of Q1 2026.
  • Quarry LP bought 200 Edgewise Therapeutics shares in Q1 2026, an estimated $5.77K.
  • Edgewise Therapeutics made up 0.03% of Quarry LP's portfolio in Q1 2026, its #347 holding.
  • Quarry LP first reported a position in Edgewise Therapeutics in Q2 2024 and has held it in 7 quarters since.
  • Quarry LP's Edgewise Therapeutics position peaked at $252K in Q2 2024.
  • 214 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q1 2026.

Based on Quarry LP's 13F filing for Q1 2026, filed 15 May 2026.